4.6 Article

Affective Dysregulation and Reality Distortion: A 10-Year Prospective Study of Their Association and Clinical Relevance

期刊

SCHIZOPHRENIA BULLETIN
卷 37, 期 3, 页码 561-571

出版社

OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbp101

关键词

epidemiology; adolescent; psychosis; affective symptoms

资金

  1. German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung) [01EB9405/6, 01EB 9901/6, EB01016200, 01EB0140, 01EB0440]
  2. Deutsche Forschungsgemeinschaft [LA1148/1-1, WI2246/1-1, WI 709/7-1, WI 709/8-1]
  3. Novartis
  4. Pfizer
  5. Schering-Plough
  6. Eli Lilly
  7. BMS
  8. Lundbeck
  9. Organon
  10. Janssen-Cilag
  11. GSK
  12. AstraZeneca
  13. Servier-companies

向作者/读者索取更多资源

Evidence from clinical patient populations indicates that affective dysregulation is strongly associated with reality distortion, suggesting that a process of misassignment of emotional salience may underlie this connection. To examine this in more detail without clinical confounds, affective regulation-reality distortion relationships, and their clinical relevance, were examined in a German prospective cohort community study. A cohort of 2524 adolescents and young adults aged 14-24 years at baseline was examined by experienced psychologists. Presence of psychotic experiences and (hypo)manic and depressive symptoms was assessed at 2 time points (3.5 and up to 10 years after baseline) using the Munich-Composite International Diagnostic Interview. Associations were tested between level of affective dysregulation on the one hand and incidence of psychotic experiences, persistence of these experiences, and psychotic Impairment on the other. Most psychotic experiences occurred in a context of affective dysregulation, and bidirectional dose-response was apparent with greater level of both affective dysregulation and psychotic experiences. Persistence of psychotic experiences was progressively more likely with greater level of (hypo)manic symptoms (odds ratio [OR] trend = 1.51, P < .001) and depressive symptoms (OR trend = 1.15, P = .012). Similarly, psychotic experiences of clinical relevance were progressively more likely to occur with greater level of affective dysregulation (depressive symptoms: OR trend = 1.28, P = .002; (hypo)manic symptoms: OR trend = 1.37, P = .036). Correlated genetic liabilities underlying affective and nonaffective psychotic syndromes may be expressed as correlated dimensions in the general population. Also, affective dysregulation may contribute causally to the persistence and clinical relevance of reality distortion, possibly by facilitating a mechanism of aberrant salience attribution.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据